| Number of events | Year of event | No. false positives (PPV) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |||
Cystectomy | Reference | NA | NA | 16 | 21 | 28 | 26 | 41 | 34 | 34 | 6 | NA | 8 (0.96) |
Routine data (HID) | NA | NA | 16 | 21 | 25 | 25 | 41 | 34 | 34 | 6 | NA | ||
Sensitivity (%) | – | – | 100.0 | 100.0 | 89.3 | 96.2 | 100.0 | 100.0 | 100.0 | 100.0 | - | ||
Radiotherapy regimen | Reference | NA | NA | NA | 74 | 83 | 72 | 67 | 79 | 93 | 68 | 32 | 20 (0.95) |
Routine data (HID) | NA | NA | NA | 1 | 1 | 55 | 66 | 79 | 92 | 68 | 29 | ||
Sensitivity (%) | – | – | – | 1.4 | 1.2 | 76.4 | 98.5 | 100.0 | 98.9 | 100.0 | 90.6 | ||
Censor | Reference | NA | NA | 1 | 5 | 4 | 8 | 16 | 11 | 9 | 27 | 19 | 0 (1.00) |
Routine data (HID) | NA | NA | 1 | 5 | 4 | 8 | 16 | 11 | 9 | 22 | 13 | ||
Sensitivity (%) | – | – | NA | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 81.5 | 68.4 | ||
BCG regimen | Reference | NA | NA | 1 | 3 | 1 | 4 | 2 | 3 | 1 | NA | NA | 20 (0.41) |
Routine data (HID) | NA | NA | 1 | 3 | 0 | 4 | 2 | 3 | 1 | NA | NA | ||
Sensitivity (%) | – | – | NA | 100.0 | – | 100.0 | 100.0 | 100.0 | – | – | – | ||
Cystoscopy | Reference | NA | 3 | 8 | 8 | 21 | 20 | 15 | 15 | 9 | 5 | 2 | 6 (0.94) |
Routine data (HID) | NA | 2 | 6 | 6 | 19 | 17 | 12 | 11 | 9 | 5 | 2 | ||
Sensitivity (%) | – | 66.7 | 75.0 | 75.0 | 90.5 | 85.0 | 80.0 | 73.3 | 100.0 | 100.0 | 100.0 | ||
Chemotherapy regimen | Reference | 1 | 1 | 4 | 6 | 7 | 9 | 5 | 7 | 3 | 3 | 1 | 3 (0.94) |
Routine data (HID) | 0 | 0 | 4 | 5 | 7 | 9 | 5 | 7 | 3 | 3 | 1 | ||
Sensitivity (%) | – | – | 100.0 | 83.3 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | – |